Rainer Henning, PhD (Chief Executive Officer)

combines extensive experience in both the pharmaceutical and biotech industry with professional background as investment manager. Prior to joining Biomay he successfully served as CEO of Fibrex Medical Inc. At Hoechst AG (now part of Sanofi Aventis) he held several positions including Deputy Head of Cardiovascular Research and was Managing Director of Nippon Hoechst Marion Roussel. He co-invented the blockbuster antihypertensives Tritace® and Odrik® and authored well over 80 granted patents. At Future Capital and Brilleon Capital he served as investment manager and partner.